Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Long-Term Deferred Tax (2016 - 2021)

Historic Long-Term Deferred Tax for cbdMD (YCBD) over the last 6 years, with Q3 2021 value amounting to $13.0 million.

  • cbdMD's Long-Term Deferred Tax rose 3049.91% to $13.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $13.0 million, marking a year-over-year increase of 3049.91%. This contributed to the annual value of $13.0 million for FY2021, which is 3049.91% up from last year.
  • Per cbdMD's latest filing, its Long-Term Deferred Tax stood at $13.0 million for Q3 2021, which was up 3049.91% from $10.0 million recorded in Q3 2020.
  • cbdMD's 5-year Long-Term Deferred Tax high stood at $13.0 million for Q3 2021, and its period low was $19000.0 during Q1 2018.
  • Moreover, its 5-year median value for Long-Term Deferred Tax was $4.6 million (2017), whereas its average is $5.7 million.
  • As far as peak fluctuations go, cbdMD's Long-Term Deferred Tax crashed by 3388.09% in 2018, and later soared by 32265.22% in 2019.
  • cbdMD's Long-Term Deferred Tax (Quarter) stood at $2.4 million in 2017, then plummeted by 33.88% to $1.6 million in 2018, then soared by 322.65% to $6.8 million in 2019, then surged by 46.91% to $10.0 million in 2020, then skyrocketed by 30.5% to $13.0 million in 2021.
  • Its Long-Term Deferred Tax was $13.0 million in Q3 2021, compared to $10.0 million in Q3 2020 and $6.8 million in Q3 2019.